Category Archives: HIV care & treatment

FDA approves two new doses of elvitegravir, in addition to its current use in Stribild

post_vitekta

On September 24, 2014, the FDA approved two new standalone doses of the integrase inhibitor elvitegravir, which now comes with the brand name Vitekta. The 85mg dose can be taken with Reyataz (atazanavir) and Kaletra (lopinavir), while the 150mg dose can be taken with Prezista (darunavir),…Read More

New version of tenofovir appears to be safe and effective

post_taf

On September 24, 2014, early results were released from two 96-week clinical studies of a new form of tenofovir (TAF, or tenofovir alafenamide), compared to its currently available form (TDF, or tenofovir disoproxil fumurate). Results show about equal suppression of HIV infection and improvements with certain…Read More

FDA approves new HIV drug booster cobicistat as standalone pill

post_tybost

On September 24, 2014, the FDA approved the drug cobicistat as a booster for two HIV medications: atazanavir (Reyataz) and darunavir (Prezista). The drug is used to maintain the blood levels of certain HIV drugs; however, it does not directly inhibit the HIV life cycle. It…Read More

Egrifta distribution resumes in the US to replenish supply chain

post_egrifta

Note from Project Inform: For patients who had their Egrifta prescription refills interrupted, it is likely you/your provider will need to fill out initial paperwork to re-start Egrifta, because this is a new company that’s responsible for its distribution. Other than that, there shouldn’t be any…Read More

NIH-led scientists discover HIV antibody that binds to novel target on virus

post_gp41gp120

WHAT: An NIH-led team of scientists has discovered a new vulnerability in the armor of HIV that a vaccine, other preventive regimen or treatment could exploit. The site straddles two proteins, gp41 and gp120, that jut out of the virus and augments other known places where…Read More

HIV medical organizations challenge insurer restrictions to HCV treatment

post_hcvmedicaid

WASHINGTON, DC – The American Academy of HIV Medicine (AAHIVM) and the HIV Medicine Association (HIVMA), the two largest professional associations representing HIV clinicians in the U.S., are challenging new health plan cost control policies barring many qualified HIV care providers from prescribing certain medications that treat…Read More

The ACE TA Center: Affordable Care Enrollment for the Ryan White Community

post_ACEcenter

If you or your agency is looking for support around helping clients gain access to health insurance, the ACE TA Center may be able to help. “The goal of the ACE TA Center is to help RWHAP grantees and providers enroll diverse clients, especially people of…Read More